Moderna, Pfizer test vaccine strategies against new variants
Pfizer and its partner BioNTech said Thursday they have begun to test how well adding a third dose of their authorized vaccine might protect against new variants. |!| Chattanooga
Pfizer and its partner BioNTech said Thursday they have begun to test how well adding a third dose of their authorized vaccine might protect against new variants. |!| Chattanooga